Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data.
about
Spinal cord injury: a review of current therapy, future treatments, and basic science frontiersClinical outcome of autologous mononuclear cells transplantation for spinal cord injury: a systematic review and meta-analysisLocal injection of autologous bone marrow cells to regenerate muscle in patients with traumatic brachial plexus injury: a pilot study.Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.Clinical and experimental advances in regeneration of spinal cord injury.Immunophenotypic comparison of heterogenous non-sorted versus sorted mononuclear cells from human umbilical cord blood: a novel cell enrichment approach.Pilot study: bone marrow stem cells as a treatment for dogs with chronic spinal cord injury.Human umbilical cord mesenchymal stem cells promote peripheral nerve repair via paracrine mechanismsNeuronal Differentiation of Human Mesenchymal Stem Cells Using Exosomes Derived from Differentiating Neuronal Cells.Cellular therapies for treating pain associated with spinal cord injurySurface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrowAdvances in stem cell therapy for spinal cord injury.Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model.Cellular Therapies in Trauma and Critical Care Medicine: Forging New FrontiersA clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injuryPreliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury.Microelectrode arrays in combination with in vitro models of spinal cord injury as tools to investigate pathological changes in network activity: facts and promisesCurrent status of cell-mediated regenerative therapies for human spinal cord injury.Functional recovery in chronic stage of spinal cord injury by neurorestorative approach: a case report.Stem Cell Transplantation for Peripheral Nerve Regeneration: Current Options and Opportunities.Effects of different sera conditions on olfactory ensheathing cells in vitro.Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation.Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications.A comprehensive study on optimization of proliferation and differentiation potency of bone marrow derived mesenchymal stem cells under prolonged culture condition.Biomaterial-Supported Cell Transplantation Treatments for Spinal Cord Injury: Challenges and Perspectives.Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).
P2860
Q27025166-D7D68BCD-59FE-4B1B-B3D9-9C9CC730E61DQ28087139-BA01FEAF-4632-4C06-917A-A827D2CFD117Q30573375-7356DF71-E17C-4580-A501-F3A08FE1DC69Q34482943-9662574E-0B6E-46DF-AC39-BF751E81478AQ34591366-66AFC7C3-68F6-4AEE-8423-22D719E0DEA0Q34962297-48898861-34B2-45D3-B61A-EE672BC98E0EQ35576889-C40DD774-5D1D-4CFD-8462-B31F89B134C0Q35584618-1812009A-92EF-4904-A84C-ABD40C9D8298Q35738989-2CFF19CF-826D-4268-838E-4D3F46C92663Q35873511-29439C17-E836-4CE1-A22D-4FCC978E7853Q36204478-1A7F6C33-3549-4BAA-B699-7A99F4EC2B16Q36357908-463D3246-690A-46D2-8B3F-871F38AF6593Q36668099-740FC943-E06B-46EF-869C-BD90924549ABQ36852274-929946A3-61CE-4FB5-B6E9-DCE10F507D06Q37075524-91FB141B-7950-42E5-8088-FD5003DD0856Q37635476-176FA029-43F3-4904-9773-6EF844B5B3D7Q38086423-A81F7DAB-92EF-4BC8-8F05-18CD1AD348C7Q38210966-A6001431-7497-4D13-990E-3433AF25E35CQ38590332-A0BFA763-3080-435A-8ED7-FBDD0010B3E9Q39032002-8F66DF0F-9210-4F47-B243-DFCE06B1D0FCQ41935601-711CC983-F1F7-43F3-956D-C3A94D442112Q42323938-3D557A47-6A29-4392-A8C3-AE71AF1AF90AQ42706941-F541DC69-AA8E-4B9C-9062-65AC8312D2B4Q43026554-9396B220-5656-4566-8ADC-DF8DBD2D91EFQ49164561-FFF9C74B-333D-4321-9F64-24409E988787Q52594563-7E654FBE-E4C5-4F3F-9C00-DD76AA12D279
P2860
Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Autologous bone marrow derived ...... ety and primary efficacy data.
@ast
Autologous bone marrow derived ...... ety and primary efficacy data.
@en
Autologous bone marrow derived ...... ety and primary efficacy data.
@nl
type
label
Autologous bone marrow derived ...... ety and primary efficacy data.
@ast
Autologous bone marrow derived ...... ety and primary efficacy data.
@en
Autologous bone marrow derived ...... ety and primary efficacy data.
@nl
prefLabel
Autologous bone marrow derived ...... ety and primary efficacy data.
@ast
Autologous bone marrow derived ...... ety and primary efficacy data.
@en
Autologous bone marrow derived ...... ety and primary efficacy data.
@nl
P2093
P1476
Autologous bone marrow derived ...... ety and primary efficacy data.
@en
P2093
Arachimani Anand Kumar
Kanagarajan Arul
Mayakesavan Baskaran
Raghavachary Narayanan
Sankaran Raj Kumar
P304
P577
2009-12-01T00:00:00Z